Lv14
20 积分 2026-03-31 加入
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
5小时前
已完结
Natural history and progression of metabolic dysfunction-associated steatotic liver disease
22小时前
已完结
Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis
3天前
已完结
Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis
3天前
已完结
皖公网安备34019202002308
